Study of cell-type specific Alzheimer's disease genetic variants using a novel bioengineered model of iPSC-derived neural tissue
使用 iPSC 衍生神经组织的新型生物工程模型研究细胞类型特异性阿尔茨海默病遗传变异
基本信息
- 批准号:10399527
- 负责人:
- 金额:$ 97.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-05-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAbeta clearanceAction PotentialsAffectAgingAllelesAlzheimer like pathologyAlzheimer&aposs DiseaseAlzheimer&aposs disease brainAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAlzheimer&aposs disease riskAmyloid beta-42Amyloid beta-ProteinAnimal Disease ModelsAnimal ModelApolipoprotein EApolipoproteinsArchitectureAstrocytesAxonBindingBiomedical EngineeringBrainCell Culture TechniquesCell DensityCell LineCell Surface ProteinsCell TransplantationCell modelCellsCholesterol HomeostasisCodeCognitiveCollagenComplementComplexDataDeteriorationDiffusionElectrophysiology (science)FamilyFunctional disorderGene ExpressionGenesGenetic PolymorphismGenotypeGrowthHomeostasisHumanIn VitroInduced pluripotent stem cell derived neuronsLate Onset Alzheimer DiseaseLearningLinkMammalsMemoryMemory impairmentMetabolicMicrogliaModelingMusMutationMyeloid CellsNecrosisNerve DegenerationNeurodegenerative DisordersNeurogliaNeuronsNutrientOpticsOxygenPathogenesisPathologicPatientsPhagocytosisPhenotypePhysiologicalPopulationPoriferaProteinsRiskRisk FactorsRodentSenile PlaquesSilkSleepSynapsesSynaptic TransmissionSynaptic plasticitySystemTREM2 geneTechnologyTimeTissue ModelTissuesTransplant RecipientsTransplantationVariantabeta depositionapolipoprotein E-4basebeta secretasebrain behaviorcell typeearly onsetexomeextracellularfamilial Alzheimer diseasegenetic variantgenome editinggenome sequencinggenome wide association studyhuman subjectin vivoinduced pluripotent stem cellinnovationlipid metabolismmembermolecular phenotypemutantneonatal miceneuronal excitabilitynovelprecursor cellreceptorrelating to nervous systemrisk variantscaffoldstem cell technologysynaptic functionsynaptogenesisthree dimensional cell culturetraffickingwhole genome
项目摘要
ABSTRACT
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by memory impairments
and cognitive deterioration. Aging is the major risk factor for AD. Furthermore, increasing evidence indicates
that astrocytes and microglia are implicated in the pathogenesis of AD. The ε4 allele of the apolipoprotein E
gene (APOE) has been identified as a major risk factor contributing to the pathogenesis of sporadic AD (SAD)
in about 15-20% of the cases. APOE is the major apolipoprotein expressed in the human brain primarily by
astrocytes and to a lesser extent by microglia, and is involved in cholesterol homeostasis, and regulates A
clearance. Furthermore, genome-wide association studies (GWAS) have identified polymorphisms in genes
enriched in microglia (e.g. SORL1, CR1, CD2AP, CD33, TREM2, ABCA7) and astrocytes (e.g. CLU and
ABCA7) that increase the risk of developing AD. Recent advances in stem cell technology have allowed the
reprogramming of primary cells from human subjects into induced pluripotent stem cells (iPSCs) and their
differentiation in neurons, astrocytes and microglia. However, conventional 2D culture systems fail to
recapitulate the diversity and maturation of multiple cell types and their interaction under physiological and
pathological conditions. To overcome these weaknesses we have developed a novel bioengineered model of
iPSC-derived neural tissue. Our silk-collagen protein-based ‘donut’ scaffolds can support compartmentalized,
3D brain-like tissues over a year, without necrosis. This tissue model is highly innovative, supporting the
differentiating neurons growth in a donut-shaped porous silk sponge within an optically cleared collagen-filled
central region for axon connectivity and synapse formation, that will allow for the first time live in vivo studies
(e.g., cell-based electrophysiology, trafficking, synaptic functionality) of an human AD brain-like tissue during
ageing (months of cultivation) under controlled experimental conditions. More importantly, the architecture of
the scaffolds was optimized to meet the metabolic demand of high-density cell cultures in terms of free
diffusion of nutrients and oxygen, a fundamental requisite for long-term cultures and ageing-related studies.
Thus, we propose to: 1) Assess genotype-phenotype relationship of AD genetic variants enriched in astrocytes
and microglia in patient-derived 3D brain-like cultures; 2) Assess genotype-phenotype relationship of AD
genetic variants in vivo after transplantation of patient-derived cells in mice.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PHILIP G HAYDON其他文献
PHILIP G HAYDON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PHILIP G HAYDON', 18)}}的其他基金
Study of cell-type specific Alzheimer's disease genetic variants using a novel bioengineered model of iPSC-derived neural tissue
使用 iPSC 衍生神经组织的新型生物工程模型研究细胞类型特异性阿尔茨海默病遗传变异
- 批准号:
10630194 - 财政年份:2020
- 资助金额:
$ 97.59万 - 项目类别:
Study of cell-type specific Alzheimer's disease genetic variants using a novel bioengineered model of iPSC-derived neural tissue
使用 iPSC 衍生神经组织的新型生物工程模型研究细胞类型特异性阿尔茨海默病遗传变异
- 批准号:
9980545 - 财政年份:2020
- 资助金额:
$ 97.59万 - 项目类别:
Astrocyte-derived lactate modulates orexinergic neuron activity and behavior
星形胶质细胞衍生的乳酸调节食欲素能神经元的活动和行为
- 批准号:
9904787 - 财政年份:2018
- 资助金额:
$ 97.59万 - 项目类别:
Astrocyte-derived lactate modulates orexinergic neuron activity and behavior
星形胶质细胞衍生的乳酸调节食欲素能神经元的活动和行为
- 批准号:
10376203 - 财政年份:2018
- 资助金额:
$ 97.59万 - 项目类别:
Glial dependent modulation of depressive like behaviors
抑郁样行为的神经胶质依赖性调节
- 批准号:
8452671 - 财政年份:2012
- 资助金额:
$ 97.59万 - 项目类别:
Roles for Astrocytes in Mediating Responses to Alcohol
星形胶质细胞在介导酒精反应中的作用
- 批准号:
8541681 - 财政年份:2012
- 资助金额:
$ 97.59万 - 项目类别:
Roles for Astrocytes in Mediating Responses to Alcohol
星形胶质细胞在介导酒精反应中的作用
- 批准号:
8668830 - 财政年份:2012
- 资助金额:
$ 97.59万 - 项目类别:
Glial dependent modulation of depressive like behaviors
抑郁样行为的神经胶质依赖性调节
- 批准号:
8319749 - 财政年份:2012
- 资助金额:
$ 97.59万 - 项目类别:
Roles for Astrocytes in Mediating Responses to Alcohol
星形胶质细胞在介导酒精反应中的作用
- 批准号:
8256163 - 财政年份:2012
- 资助金额:
$ 97.59万 - 项目类别:
Roles for Astrocytes in Mediating Responses to Alcohol
星形胶质细胞在介导酒精反应中的作用
- 批准号:
9064023 - 财政年份:2012
- 资助金额:
$ 97.59万 - 项目类别:
相似海外基金
Environmental copper exposure and its impact on microglial Abeta clearance
环境铜暴露及其对小胶质细胞 Abeta 清除的影响
- 批准号:
8757425 - 财政年份:2014
- 资助金额:
$ 97.59万 - 项目类别:
Development of Novel Therapies for AD Targeting Abeta Clearance
针对 Abeta 清除的 AD 新型疗法的开发
- 批准号:
8820188 - 财政年份:2014
- 资助金额:
$ 97.59万 - 项目类别:
Development of Novel Therapies for AD Targeting Abeta Clearance
针对 Abeta 清除的 AD 新型疗法的开发
- 批准号:
9040023 - 财政年份:2014
- 资助金额:
$ 97.59万 - 项目类别:
Environmental copper exposure and its impact on microglial Abeta clearance
环境铜暴露及其对小胶质细胞 Abeta 清除的影响
- 批准号:
8930156 - 财政年份:2014
- 资助金额:
$ 97.59万 - 项目类别:
Caloric restriction and Alzheimers ABeta clearance pathway
热量限制和阿尔茨海默病 Aβ 清除途径
- 批准号:
8897941 - 财政年份:2013
- 资助金额:
$ 97.59万 - 项目类别:
Caloric restriction and Alzheimers ABeta clearance pathway
热量限制和阿尔茨海默病 Aβ 清除途径
- 批准号:
8411069 - 财政年份:2013
- 资助金额:
$ 97.59万 - 项目类别:
Caloric restriction and Alzheimers ABeta clearance pathway
热量限制和阿尔茨海默病 Aβ 清除途径
- 批准号:
8713897 - 财政年份:2013
- 资助金额:
$ 97.59万 - 项目类别:
The role of human ApoE in soluble ABeta clearance through the LDLR in vivo
人 ApoE 在体内通过 LDLR 清除可溶性 Aβ 中的作用
- 批准号:
7752282 - 财政年份:2009
- 资助金额:
$ 97.59万 - 项目类别:
The role of human ApoE in soluble ABeta clearance through the LDLR in vivo
人 ApoE 在体内通过 LDLR 清除可溶性 Aβ 中的作用
- 批准号:
8090296 - 财政年份:2009
- 资助金额:
$ 97.59万 - 项目类别:
Development of therapeutics for dementia targeting Abeta clearance
开发针对 Abeta 清除的痴呆疗法
- 批准号:
20590697 - 财政年份:2008
- 资助金额:
$ 97.59万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




